ANNA MALOVANNAYA to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Xenograft Model Antitumor Assays.
Connection Strength
0.336
-
gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data. Mol Cell Proteomics. 2018 11; 17(11):2270-2283.
Score: 0.126
-
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 03 28; 8:14864.
Score: 0.114
-
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 Feb 06; 145(6):612-624.
Score: 0.049
-
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood. 2024 05 16; 143(20):2059-2072.
Score: 0.047